Mary Ann Gray Bio Atla, Inc. (BCAB) insider trading activity

BCAB Quotes by TradingView

Mary Ann Gray is of BioAtla, Inc.. Currently has a direct ownership of 77,397 shares of BCAB, which is worth approximately $28,636. The most recent transaction as insider was on Jun 18, 2025, when has been sold 23,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77.4K
43.6% 3M change
43.6% 12M change
Total Value Held $28,636

MARY ANN GRAY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
BUY
Grant, award, or other acquisition
-
23,500 Added 23.29%
77,397 Common Stock
Jun 13 2024
BUY
Grant, award, or other acquisition
-
16,500 Added 23.44%
53,897 Common Stock
Dec 31 2023
BUY
Grant, award, or other acquisition
-
5,995 Added 13.82%
37,397 Common Stock
Sep 30 2023
BUY
Grant, award, or other acquisition
-
8,676 Added 21.65%
31,402 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
-
4,916 Added 17.78%
22,726 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
-
5,503 Added 23.6%
17,810 Common Stock

Also insider at

SRPT
Sarepta Therapeutics, Inc. Healthcare
Director
KROS
Keros Therapeutics, Inc. Healthcare
RAPT
RAPT Therapeutics, Inc. Healthcare
PALI
PALISADE BIO, INC. Healthcare
Director
CMPX
Compass Therapeutics, Inc. Healthcare
Director
MAG

Mary Ann Gray

Cambridge, MA

Track Institutional and Insider Activities on BCAB

Follow BioAtla, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCAB shares.

Notify only if

Insider Trading

Get notified when an Bio Atla, Inc. insider buys or sells BCAB shares.

Notify only if

News

Receive news related to BioAtla, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCAB